Systematic identification of perioperative neurocognitive disorder related biomarkers in Alzheimer’s disease and development of machine learning-based diagnostic models
This study integrates multi-omics analysis, machine learning, and experimental validation to identify six conserved biomarkers linking Alzheimer's disease and perioperative neurocognitive disorder, leading to the development of a diagnostic nomogram and the proposal of shared immune-metabolic mechanisms and therapeutic targets.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of a preprint that has not been peer-reviewed. It is not medical advice. Do not make health decisions based on this content. Read full disclaimer
The human brain is a complex organ that relies on delicate chemical signals to maintain memory and thought. When these signals falter, the result can be a slow, progressive decline known as Alzheimer's disease, a condition that currently affects millions of people worldwide. This disease is characterized by the buildup of harmful proteins and a chronic state of inflammation within the brain, which eventually damages nerve cells. Interestingly, a similar pattern of cognitive trouble can occur suddenly in older adults after they undergo surgery. This temporary or long-lasting confusion, often called perioperative neurocognitive disorder, shares many of the same biological warning signs as Alzheimer's. Because these two conditions seem to walk the same biological path, researchers have begun to wonder if the molecular clues found in one could help diagnose or treat the other.
A team of scientists at Qingdao University in China set out to explore this connection by looking for shared genetic signatures between Alzheimer's disease and the cognitive changes seen after surgery. They started by gathering vast amounts of genetic data from previous studies, focusing on the hippocampus, a part of the brain critical for memory. Using powerful computer programs, they compared the genetic activity in brains affected by Alzheimer's against healthy brains. This process allowed them to filter through thousands of genes to find the specific ones that were behaving differently. They then cross-referenced these findings with genes known to be involved in post-surgical cognitive issues, narrowing their search to a specific group of 167 genes that appeared in both contexts.
To make sense of this large group, the researchers built a digital map of how these genes interact with one another, much like charting a network of friends who all know each other. Within this network, they identified the most central and influential players. They then applied a type of artificial intelligence, known as a machine learning algorithm, to test which of these genes were the most reliable at distinguishing between a healthy brain and one with Alzheimer's. This computational screening whittled the list down to ten top candidates. To ensure these findings were not just a fluke of one dataset, the team tested these ten genes in a second, independent group of patient data. This second round of testing confirmed that six of the genes consistently showed the same patterns: some were significantly higher in Alzheimer's patients, while others were significantly lower. These six genes—RB1, PARK7, GLO1, ENO2, MDH2, and TUBB—were confirmed as robust biological markers.
With these six markers in hand, the researchers constructed a diagnostic tool called a nomogram. This is a visual chart that combines the levels of all six genes to calculate the probability that a patient has Alzheimer's. When they tested this tool, it proved highly accurate, correctly identifying the disease in 85 percent of the cases in their validation group. The study also looked deeper into what these genes actually do. They found that these markers are involved in the body's immune response and how cells manage energy. For instance, some of the genes are linked to how the brain fights inflammation, while others are tied to the production of energy within cells. This suggests that the confusion seen after surgery and the memory loss of Alzheimer's may both stem from a breakdown in how brain cells handle stress and immune threats.
To see if these genetic patterns held true in a living system, the team turned to a mouse model of Alzheimer's. They examined the brains of these mice and measured the levels of the six identified genes. The results mirrored what they had seen in human data: the gene RB1 was elevated, while PARK7, ENO2, and MDH2 were reduced. Although the changes in the other two genes were not statistically significant in the mice, the overall direction of the changes matched the human findings, suggesting these markers are a consistent feature of the disease across species. Finally, the researchers used their list of six genes to search for existing drugs that might target them. They discovered that several known compounds, including curcumin and naringenin, could potentially interact with these genes. These substances have shown promise in earlier studies for reducing brain inflammation and protein buildup, offering a potential pathway for new treatments that could help both post-surgical patients and those with Alzheimer's.
The study concludes that the molecular changes occurring after surgery are not just a temporary side effect but are deeply connected to the long-term mechanisms of Alzheimer's disease. By identifying these six specific genes, the researchers have provided a new set of tools that could help doctors diagnose the disease earlier and more accurately. While the work is still in the research phase and requires further testing before it can be used in clinics, it offers a clear view of how the brain's response to stress and inflammation might be the common thread linking acute surgical confusion with chronic memory loss. This discovery opens a door for future therapies that could target these shared pathways, potentially slowing the progression of neurodegeneration in vulnerable patients.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.